Market Tracker

02/20 1:05pm ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

10.78
Delayed Data
As of Feb 17
 -0.05 / -0.46%
Today’s Change
6.10
Today|||52-Week Range
13.80
+28.03%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close10.83
Today’s open10.81
Day’s range10.47 - 10.90
Volume119,092
Average volume (3 months)62,101
Market cap$199.8M
Dividend yield36.34%
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-1.14%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.25+2.18%
NATRNatures Sunshine Pro...+0.15+1.27%
CTSOCytosorbents Corp0.000.00%
CDXCChromadex Corp+0.02+0.70%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts